BIOTRICITY INC. Increase (Decrease) in Accounts and Other Receivables
BIOTRICITY INC. (BTCY) reported Increase (Decrease) in Accounts and Other Receivables of $1.04 million for the 9-month period ending 2025-12-31, per its 10-Q filed 2026-02-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables · last filed 2026-02-11
- BIOTRICITY INC. increase (decrease) in accounts and other receivables for the quarter ending 2025-12-31 was -$665.34K, a 405.54% decline year-over-year.
- BIOTRICITY INC. increase (decrease) in accounts and other receivables for the quarter ending 2025-09-30 was -$125.49K, a 222.53% decline year-over-year.
- BIOTRICITY INC. increase (decrease) in accounts and other receivables for the quarter ending 2025-06-30 was $1.83M, a 31.20% increase year-over-year.
- BIOTRICITY INC. increase (decrease) in accounts and other receivables for the quarter ending 2025-03-31 was -$176.49K.
- BIOTRICITY INC. increase (decrease) in accounts and other receivables for fiscal 2024 was $1.29M.
| Period end | Increase (Decrease) in Accounts and Other Receivables 3 month | Increase (Decrease) in Accounts and Other Receivables 6 month | Increase (Decrease) in Accounts and Other Receivables 9 month | Increase (Decrease) in Accounts and Other Receivables 12 month |
|---|---|---|---|---|
| 2025-12-31 | -$665.34K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-11 | -$790.83K derived: sum of 2 quarters · filed 2026-02-11 | $1.04M 10-Q · filed 2026-02-11 | $867.07K derived: sum of 4 quarters · filed 2026-02-11 |
| 2025-09-30 | -$125.49K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-14 | $1.71M 10-Q · filed 2025-11-14 | $1.53M derived: sum of 3 quarters · filed 2026-02-11 | $1.75M derived: sum of 4 quarters · filed 2026-02-11 |
| 2025-06-30 | $1.83M 10-Q · filed 2025-08-14 | $1.66M derived: sum of 2 quarters · filed 2026-02-11 | $1.88M derived: sum of 3 quarters · filed 2026-02-11 | $1.98M derived: sum of 4 quarters · filed 2026-02-11 |
| 2025-03-31 | -$176.49K derived: 10-Q 12 month − 10-Q/A 9 month · filed 2026-02-11 | $41.27K derived: sum of 2 quarters · filed 2026-02-11 | $143.69K derived: sum of 3 quarters · filed 2026-02-11 | $1.54M 10-Q · filed 2026-02-11 |
| 2024-12-31 | $217.76K derived: 10-Q/A 9 month − 10-Q 6 month · filed 2025-02-20 | $320.18K derived: sum of 2 quarters · filed 2025-02-20 | $1.72M 10-Q/A · filed 2025-02-20 | |
| 2024-09-30 | $102.42K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-11-14 | $1.50M 10-Q · filed 2024-11-14 | ||
| 2024-06-30 | $1.40M 10-Q · filed 2024-08-19 | |||
| 2024-03-31 | $1.29M 10-K/A · filed 2025-07-18 |